Abstract
Bone fragility has emerged as a key clinical manifestation of cystic fibrosis, a genetic disease caused by CFTR mutation, which is not well understood and currently lacks effective therapeutic options. Here we report that CFTR is downregulated in aged wild-type mouse bones; CFTR-deficient mice show early activation of bone cell senescence, abnormal bone micro-architecture, altered osteogenic genes expression and impaired bone fracture healing, mimicking age-related bone disease. We also observed that magnesium ion enters bone cells, activates a transcription factor, ATF4, and promotes Wnt/β-catenin signaling. Magnesium implant improves bone fracture healing in CFTR-mutant mice, which is blocked by Wnt/β-catenin inhibition or ATF4 knockdown. Importantly, oral magnesium or local administration of VX809, a drug that restores CFTR function, improves bone quality in aged wild-type rats/mice. Together, these results collectively show that CFTR-deficiency mimics aging to cause bone defects , while suggesting magnesium supplementation as a possible therapy for CFTR deficiency-associated bone diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
